Treatment of heart failure falls short of guidelines
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Treatment of up to a quarter of patients with heart failure does not meet the present guidelines, research has revealed.
A study of 197 patients with chronic heart problems found 23 per cent failed to be treated with ACE inhibitors - drugs which have been shown in clinical trials to reduce significantly deaths from heart failure.
Forty per cent of patients were prescribed drugs known to worsen heart failure, according to the study. Researchers at Tameside General Hospital, Manchester, told the British Pharmaceutical Conference in Scarborough that better management of heart failure patients was needed. Later today Frank Dobson Health Secretary will address the conference which runs until Thursday.
Researchers questioned all patients with a diagnosis of chronic heart failure admitted to Tameside Hospital over a 10-month period.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments